Carbamazepine Articles
Anti-epileptics to get suicide warnings in USA
22 December 2008
New Rxing info for carbamazepine agreed
17 December 2007
Validus acquires Shire's Equetro
17 September 2007
Keppra "non-inferior" to CR carbamazepine
5 March 2007
Headlines 25 years ago this week....
26 July 2006
Shire's net income improves 75% in 1st qtr
8 May 2006
Shire and Impax settle Adderall dispute
30 January 2006
Nostrum "confident" on Shire litigation
1 August 2005
Shire launches Equetro in USA
22 April 2005
Shire's Equetro cleared by FDA for BD
20 December 2004
UK NICE OKs Novartis' Gleevec as first-line GIST management, also views epilepsy care
8 November 2004
Studies reveal risk of birth defects from AEDs
13 September 2004
UK NICE guidance on insomnia drugs
10 May 2004
UK NICE backs newer antiepileptics
29 March 2004
Strong performace for Shire in 2003
22 March 2004
Shire's profits up on switching strategy
3 March 2003
Caraco expects $35M revenues in 2003
24 February 2003
Shire
12 August 2002
Revenues in 1st-qtr rise 30% at Shire
6 May 2002
Caraco gets US OK for metformin/tramadol
4 February 2002
Shire earnings jump 54% for third quarter
7 November 2001
Euro epilepsy drug sales "to grow 17.2%/year"
19 February 2001
Novartis ties up with Cephalon in UK marketing pact
7 December 2000
Novartis Trileptal approvable in USA; firm building broad franchise in
30 September 1999
Shire benefits from strong US growth
13 May 1999
Shire profits grow despite Arenol bomb
16 March 1999
Advances In CNS Therapeutics Reviewed By Lehman Analysts
30 November 1998
Shire Relatively Happy With 3rd Qtr
23 November 1998
Novartis Files For Trileptal In USA
6 October 1998
Novartis Restructures After Disappointing First Half
1 September 1998
Explosion At Arenol To Hit Shire Profits In 4th Qtr
18 August 1998
Shire Launches Carbatrol
30 April 1998
Taro's Carbamazepine Cleared In UK
23 April 1998
Modest Rise In Sales At Novartis Lower Than Expected
22 April 1998
Elan's Zonisamide Nears US Approval
25 March 1998
Asta Comes Through Tough Year, Looks To Expansion
4 March 1998
Carbatrol Agreement Redrawn
29 December 1998
Max-GB To Double Penicillin Output
4 December 1997
Net Income And EPS Soar At Ireland's Elan Corp
22 October 1997
Shire And Novo Nordisk: Epilepsy Drugs Cleared
16 October 1997
Shire To Merge With Richwood In $186m Takeover
6 August 1997
Epilepsy Market Sees Strong Growth
29 July 1997
New Jersey To Vote On Generic Substitution
24 June 1997
Transitional First Quarter For Elan Corp
24 April 1997
Taro Pharma Receives First Approval For Teril
30 September 1996
Ciba-Geigy Launch Tegretol-XR In USA
9 September 1996
Novartis Pipeline: A Good Fit But Cuts Are Expected
18 March 1996
Novartis Pipeline: A Good Fit But Cuts Are Expected
18 March 1996
Higher-Priced Drugs Set To Expand Epilepsy Market
12 February 1996
Ciba Reveals Pipeline With Broad Reach
17 April 1995
Encouraging Results With Tiagabine
9 January 1995
$25 Bill Latin American Pharma Market In 2000
9 January 1995
US Guidelines For Psychiatric Care, And Drugs Use
12 December 1994
Israel's Taro Outline Plans, 3rd Qtr Results
28 November 1994
Tegretol Approvable In Children
10 October 1994
Monotherapy Filing For Lamotrigine In UK
26 September 1994
BUY RECOMMENDATION FOR TEVA STOCK
11 April 1994
CIBA RESULTS FOR 1993 "AS PROMISED"
4 April 1994
ABBOTT'S DEPAKOTE FOR BIPOLAR ILLNESS
4 April 1994
NEW HOPES FOR EPILEPSY TREATMENT
12 July 1993
WORLD CNS MARKET IS LARGE AND FRAGMENTED
22 February 1993
Allergic reactions in antiepileptics.
22 June 1992
NEW DRUGS FOR EPILEPTICS
13 January 1992
Showing 1-75 of 75 articles
- 1
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
